Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safety - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Transition Between Complement Inhibitors in Paroxysmal Nocturnal Hemoglobinuria: A Study on Strategy, Effectiveness, and Safety

  • By

  • Morag Griffin

  • Bruno Fattizzo

  • Jong Wook Lee

  • Richard J. Kelly

  • Roochi Trikha

  • Yasutaka Ueda

  • Jun-ichi Nishimura

  • Christopher J. Patriquin

  • Alexander Röth

  • Petra Muus

  • Jens Panse

  • Miguel Gómez Álvarez

  • Alexandra Pike

  • Talha Munir

  • Shreyans Gandhi

  • Austin Kulasekararaj

  • July 1, 2026

Share

Original Source(s)

Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safety

  • by Morag Griffin, Bruno Fattizzo, Jong Wook Lee, Richard J. Kelly, Roochi Trikha, Yasutaka Ueda, Jun-ichi Nishimura, Christopher J. Patriquin, Alexander Röth, Petra Muus, Jens Panse, Miguel Gómez Álvarez, Alexandra Pike, Talha Munir, Shreyans Gandhi, Austin Kulasekararaj

  • July 1, 2026

Related Content

Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia

Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review

Anemia and Blood Biomarkers of Alzheimer Disease in Dementia Development